These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 36810197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Liu PQ, Duan W, Chowbay B, Wen JY, Li CG, Zhou SF.
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [Abstract] [Full Text] [Related]

  • 4. The Prediction of the Relative Importance of CYP3A/P-glycoprotein to the Nonlinear Intestinal Absorption of Drugs by Advanced Compartmental Absorption and Transit Model.
    Takano J, Maeda K, Bolger MB, Sugiyama Y.
    Drug Metab Dispos; 2016 Nov; 44(11):1808-1818. PubMed ID: 27538919
    [Abstract] [Full Text] [Related]

  • 5. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
    Elsby R, Surry DD, Smith VN, Gray AJ.
    Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
    [Abstract] [Full Text] [Related]

  • 6. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P.
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [Abstract] [Full Text] [Related]

  • 7. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS, Neuhoff S, Jamei M, Rostami-Hodjegan A.
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [Abstract] [Full Text] [Related]

  • 8. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
    Dahan A, Amidon GL.
    Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
    [Abstract] [Full Text] [Related]

  • 9. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
    Cummins CL, Jacobsen W, Benet LZ.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1036-45. PubMed ID: 11861813
    [Abstract] [Full Text] [Related]

  • 10. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A, Declèves X, Bouzom F, Ball K, Marques C, Treton X, Pocard M, Valleur P, Bouhnik Y, Panis Y, Scherrmann JM, Mouly S.
    Mol Pharm; 2010 Oct 04; 7(5):1596-607. PubMed ID: 20604570
    [Abstract] [Full Text] [Related]

  • 11. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS, Bolger MB, Walker DK, Kaddoumi A.
    Mol Pharm; 2012 Mar 05; 9(3):492-504. PubMed ID: 22264132
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J, Buddha B, Dey S, Pal D, Mitra AK.
    Am J Ther; 2004 Mar 05; 11(4):262-77. PubMed ID: 15266218
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability.
    Tan W, Chen H, Zhao J, Hu J, Li Y.
    J Pharm Pharm Sci; 2008 Mar 05; 11(3):97-105. PubMed ID: 18801310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A, Sabit H, Amidon GL.
    AAPS J; 2009 Jun 05; 11(2):205-13. PubMed ID: 19319690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.